BioSpace News Archive

Dr. Thomas B. Casale, chief medical advisor for operations with FARE (Food Allergy Research & Education) and professor of medicine and pediatrics at the University of South Florida, published a paper in The Journal of Allergy and Clinical Immunology: In Practice, “Acute At Home Management Of Anaphylaxis During The COVID-19 Pandemic.”

Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, neuroscience and biodefense, announced today the formation of a new scientific advisory board (SAB).

Physicians’ Education Resource® (PER®), a leading resource for continuing medical education, announces the return of the International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™.

Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, appointed Megan Bailey as Chief Executive Officer (CEO), promoted from Chief Commercial Officer (CCO).

BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) today announced that on April 16, 2020 its subsidiary ViralClear Pharmaceuticals, Inc. submitted an application for Vicromax(tm_ (merimepodib, or MMPD) through the FDA’s Coronavirus Treatment Acceleration Program (CTAP) to administer the drug to hospitalized patients with COVID-19.

MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that it has received notice from Bank of America that its application for a Paycheck Protection Program loan (a “PPP Loan”) under the CARES Act has been approved.

CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, today announced the production and global distribution of CentoSwab™.

Shinkowa Pharmaceutical Co., Ltd. (Head Office: Tokyo Chuo-Ward, CEO: Megumi Tanaka) is the largest nutraceutical (health supplemental food which is scientifically proved) producer of β-nicotinamide mononucleotide (NMN) blended nutraceutical, which is effective to maintain health and longevity, providing high-purity NMN to universities and researchers both domestic and foreign.

Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator and exporter, announces that it has attained medical devices establishment licensing from Health Canada, enabling the immediate usage of its quality assessment products (QAPs™) by clinical laboratories, including its QAPs to help ensure the accuracy of COVID-19 disease testing.

Colorado BioScience Association (CBSA) today welcomed new officers and members to its board of directors, including new board chair, Bob Reddy, and new board vice chair, Dr. Kathleen (Kiki) Traylor.